Course of immune thrombocytopenia according to the site of platelet destruction identified by indium‐111 platelet scintigraphy
British Journal of Haematology · 2025-01 · 206 (1) · 279-289
DOI: 10.1111/bjh.19833 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 15.10.2024. Verfasst von Pauline Durand und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Infectious Diseases, University Hospital Centre of Bordeaux, Pessac, France. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Blood Platelets, Indium Radioisotopes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In primary immune thrombocytopenia (ITP), predictors of disease evolution and treatment response are needed. Data based on the site of platelet destruction are scarce. We performed a retrospective single‐centre study of adult patients with primary ITP undergoing at least one Indium‐111 platelet scintigraphy (IPS) between 2009 and 2018. Thirty‐three patients had isolated hepatic platelet destruction (H‐group), and 97 isolated splenic destruction (S‐group). Median age at diagnosis ( p < 0.001), proportion of associated cardiovascular ( p < 0.001), organ‐specific autoimmune diseases ( p = 0.02), dependence on steroids ( p = 0.003) and failure to rituximab ( p = 0.01) were higher and relapse more frequent ( p = 0.03) in H‐group compared to non‐splenectomized patients in S‐group. Splenectomy was only performed in patients from S‐group (as patients with hepatic sequestration are not splenectomized in our centre): 79% were in relapse‐free remission at the end of a median 3.4‐year post‐IPS follow‐up, 16% relapsed. In multivariate analyses, only a history of organ‐specific autoimmune or inflammatory disease was significantly associated with hepatic sequestration (OR = 4.3, 95% CI = 1.2–15, p = 0.02). Patients with isolated hepatic sequestration were older, had more cardiovascular events and organ‐specific autoimmune diseases, greater dependence on steroids, more relapses and a decreased response rate to rituximab suggesting an increased refractoriness to immunomodulatory therapies. Patients with isolated splenic sequestration responded well to splenectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Infectious Diseases, University Hospital Centre of Bordeaux, Pessac, France.
- Department of Radiopharmacy, University Hospital Centre of Bordeaux, Pessac, France.
- Department of Nuclear Medicine, University Hospital Centre of Bordeaux, Pessac, France.
- Department of Internal Medicine, University Hospital Centre of Bordeaux, Bordeaux, France.
- UMR CNRS 5164, ImmunoconcEpT & FHU ACRONIM, Bordeaux University, Bordeaux, France.
- Faculty of Medicine, Bordeaux University, Bordeaux, France.
ORCID-Profile: Charles Mesguich, Etienne Rivière
Zitieren
APA
Durand, P., Pottier, V., Debordeaux, F., Mesguich, C., Duffau, P., Lazaro, E., Viallard, J. F., & Rivière, E. (2025). Course of immune thrombocytopenia according to the site of platelet destruction identified by indium‐111 platelet scintigraphy. British Journal of Haematology, 206(1), 279-289. https://doi.org/10.1111/bjh.19833
Vancouver
Durand P, Pottier V, Debordeaux F, Mesguich C, Duffau P, Lazaro E, et al. Course of immune thrombocytopenia according to the site of platelet destruction identified by indium‐111 platelet scintigraphy. British Journal of Haematology. 2025;206(1):279-289. doi:10.1111/bjh.19833
BibTeX
@article{Durand2025,
author = {Durand, Pauline and Pottier, Valérie and Debordeaux, Frédéric and Mesguich, Charles and Duffau, Pierre and Lazaro, Estibaliz and Viallard, Jean-François and Rivière, Etienne},
title = {Course of immune thrombocytopenia according to the site of platelet destruction identified by indium‐111 platelet scintigraphy},
journal = {British Journal of Haematology},
year = {2025},
volume = {206},
number = {1},
pages = {279--289},
doi = {10.1111/bjh.19833}
}
EUVIMED